Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA

Abstract Background To date, triple-negative breast cancer (TNBC) treatment options are limited because of the loss of target receptors and, as a result, are only managed with chemotherapy. What is worse is that TNBC is frequently developing resistance to chemotherapy. By using small interfering RNA...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Long Zhang, Chaofeng Mu, Tinghong Zhang, Dejun Yang, Chenou Wang, Qiong Chen, Lin Tang, Luhui Fan, Cong Liu, Jianliang Shen, Huaqiong Li
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2021-01-01
Serija:	Journal of Nanobiotechnology
Teme:	RNA nanoparticles XBP1 siRNA TNBC Chemoresistance
Online dostop:	https://doi.org/10.1186/s12951-020-00758-4
Oznake:	Označite Brez oznak, prvi označite!